Literature DB >> 18817763

Proteomic analysis of brain protein expression levels in NF-kappabeta p50 -/- homozygous knockout mice.

Joshua B Owen1, Wycliffe O Opii, Charles Ramassamy, William M Pierce, D Allan Butterfield.   

Abstract

The role of nuclear factor kappa B (NF-kappaB) in oxidative stress, and most recently in pro- and anti-apoptotic-related mechanistic pathways, has well been established. Because of the dual nature of NF-kappaB, the wide range of genes it regulates and the plethora of stimuli that activate it, various studies addressing the functional role of NF-kappaB proteins have resulted in a number of differing findings. The present study examined the effect of a stimulus-free environment on the frontal cortex of mice brain with the p50 subunit of NF-kappaB knocked out p50 (-/-). Homozygous p50 mice knockout (KO) and wild type (WT) were used, and at 7-9 weeks they were sacrificed and various brain regions dissected. We analyzed the levels of oxidation in the frontal cortex of both the p50 (-/-) and WT mice. There was a significant reduction in the levels of protein-bound 4-hydroxynonenal (HNE) [a lipid peroxidation product], 3-nitrotyrosine (3NT), and protein carbonyls in the p50 (-/-) mice when compared to the WT. A proteomic profile analysis identified ATP synthase gamma chain, ubiquinol-cyt-C reductase, heat shock protein 10 (Hsp10), fructose bisphosphate aldolase C, and NADH-ubiquinone oxidoreductase as proteins whose expressions were significantly increased in the p50 (-/-) mice compared to the WT. With the reduction in the levels of oxidative stress and the increase in expression of key proteins in the p50 (-/-) brain, this study suggests that the p50 subunit can potentially be targeted for the development of therapeutic interventions in disorders in which oxidative stress plays a key role.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817763      PMCID: PMC2590759          DOI: 10.1016/j.brainres.2008.09.001

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  60 in total

Review 1.  NF-kappaB activation and inhibition: a review.

Authors:  Zhengwu Sun; Roland Andersson
Journal:  Shock       Date:  2002-08       Impact factor: 3.454

2.  Quantitative evaluation of proteins in one- and two-dimensional polyacrylamide gels using a fluorescent stain.

Authors:  Julie C Nishihara; Kathleen M Champion
Journal:  Electrophoresis       Date:  2002-07       Impact factor: 3.535

3.  NF-kappaB p50 is increased in neurons surviving hippocampal injury.

Authors:  K R Pennypacker; C A Kassed; S Eidizadeh; S Saporta; P R Sanberg; A E Willing
Journal:  Exp Neurol       Date:  2001-12       Impact factor: 5.330

4.  Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity.

Authors:  B C Albensi; M P Mattson
Journal:  Synapse       Date:  2000-02       Impact factor: 2.562

5.  The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.

Authors:  C M Lauderback; J M Hackett; F F Huang; J N Keller; L I Szweda; W R Markesbery; D A Butterfield
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

Review 6.  NF-kappaB in cancer: from innocent bystander to major culprit.

Authors:  Michael Karin; Yixue Cao; Florian R Greten; Zhi-Wei Li
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

7.  The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation.

Authors:  H J Kim; K W Kim; B P Yu; H Y Chung
Journal:  Free Radic Biol Med       Date:  2000-03-01       Impact factor: 7.376

8.  Age-related neural degeneration in nuclear-factor kappaB p50 knockout mice.

Authors:  Z-Y Lu; S P Yu; J-F Wei; L Wei
Journal:  Neuroscience       Date:  2006-03-13       Impact factor: 3.590

9.  Gene deletion of NF-kappa B p50 does not alter the hepatic inflammatory response to ischemia/reperfusion.

Authors:  Atsushi Kato; Michael J Edwards; Alex B Lentsch
Journal:  J Hepatol       Date:  2002-07       Impact factor: 25.083

10.  NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes.

Authors:  J G Mabley; G Haskó; L Liaudet; F G Soriano; F Soriano; G J Southan; A L Salzman; C Szabó
Journal:  J Endocrinol       Date:  2002-06       Impact factor: 4.286

View more
  3 in total

1.  NF-kappaB activity affects learning in aversive tasks: possible actions via modulation of the stress axis.

Authors:  Michael L Lehmann; Rebecca A Brachman; Samuel J Listwak; Miles Herkenham
Journal:  Brain Behav Immun       Date:  2010-04-23       Impact factor: 7.217

2.  POTENTIAL APPLICATION OF GRAPE DERIVED POLYPHENOLS IN HUNTINGTON'S DISEASE.

Authors:  Jun Wang; Cathie M Pfleger; Lauren Friedman; Roselle Vittorino; Wei Zhao; Xianjuan Qian; Lindsay Conley; Lap Ho; Giulio M Pasinetti
Journal:  Transl Neurosci       Date:  2010-06-01       Impact factor: 1.757

3.  Mitochondrial alterations and oxidative stress in an acute transient mouse model of muscle degeneration: implications for muscular dystrophy and related muscle pathologies.

Authors:  Renjini Ramadasan-Nair; Narayanappa Gayathri; Sudha Mishra; Balaraju Sunitha; Rajeswara Babu Mythri; Atchayaram Nalini; Yashwanth Subbannayya; Hindalahalli Chandregowda Harsha; Ullas Kolthur-Seetharam; Muchukunte Mukunda Srinivas Bharath
Journal:  J Biol Chem       Date:  2013-11-12       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.